胆囊良恶性病变组织中P-504S和P63表达及临床病理意义

吕芳; 杨竹林; 苗雄鹰; 杨乐平; 罗鑫

胆囊良恶性病变组织中P-504S和P63表达及临床病理意义

详细信息

中图分类号: R575.6;R735.8
计量
- 文章访问数: 2173
- HTML全文浏览量: 12
- PDF下载量: 1134
- 被引次数: 0
出版历程
- 出版日期: 2009-03-20

摘要

摘要: 目的研究胆囊腺癌、癌旁组织和慢性胆囊炎组织中的α-甲酰基辅酶A消旋酶（P504S）和P63蛋白表达及其临床意义。方法108例胆囊腺癌、46例癌旁组织和35例慢性胆囊炎手术切除标本常规制作石蜡包埋切片,P504S和P36染色方法为EnVisionTM免疫组化法。结果胆囊腺癌P504S和P63阳性率（51.9%,43.5%）及其评分（2.13±1.88,1.98±1.73）明显高于癌旁组织阳性率（17.9%,10.9%）及其评分（0.72±1.24,0.61±1.39）和慢性胆囊炎阳性率（14.3%,6.0%）及其评分（0.59±1.34,0.32±1.22）（P<0.01）;腺瘤癌变或高分化腺癌、无淋巴结转移及未侵犯周围组织器官病例P504S表达阳性率及其评分明显低于低分化腺癌、淋巴结转移及侵犯周围组织器官病例（P<0.05,或P<0.01）;无淋巴结转移病例P63表达阳性率及其评分明显低于转移病例（P<0.05）。结论P504S和P63表达与胆囊腺癌发生发展有密切关系,P504S可能是反映胆囊腺癌生物学行为和预后的重要生物学指标。
- 胆囊肿瘤 /
- 慢性胆囊炎 /
- α-甲酰基-辅酶A消旋酶 /
- P63 /
- 免疫组织化学
Abstract: Objective To study the expressive levels of P504S and P63 and detect their clinicopathological significances in gallbladder adenocarcinoma, pericancerous tissues and chronic cholecystitis.Methods Immunohistochemical method of EnVisionTM was used for assaying the expressive levels of P504S and P63 in routinely paraffin-embedded sections of the specimens from patients with gallbladder adenocarcinoma (n=108) , pericancerous tissues (n=46) and chronic cholecystitis (n=35) .Results The positive rates and scores of P504S and P63 in gallbladder adenocar-cinoma were significantly higher than those in pericancerous tissues and chronic cholecystitis (P<0.01) .The positive rates and scores of P504S was significantly lower in the cases of adenomatous canceration or high-differentiated adenocarcinoma, no-metastasis of lymph node and no-invasion of regional tissues than those in the ones of low-differentiated adenocarcinoma, metastasis of lymph node and invasion of regional tissues (P<0.05 or P<0.01) .The positive rate and score of P63 was significantly lower in no-metastasis of lymph node than that in metastasis of lymph node (P<0.05) .Conclusion The expression of P504S or P63 might be related to the carcinogenesis and progression of gallbladder adenocarcinoma, and P504S might be important biological marker for reflecting the biological behaviors and prognosis of gallbladder adenocarcinoma.
- gallbladder neoplasms /
- chornic cholecystitis /
- α-methylacyl-CoA racemase /
- P63 /
- immunohistochemistry

HTML全文

参考文献(15)

[1]Sung MT, Jiang Z, Montrini R, et al.Alpha-methylacyl-coAracemase (P504S) /34beta E12/P63 triple cocktail stain in prostaticadenocarcinoma after hormone therapy[J].Hum Pathol, 2007, 38 (2) ∶332-341.

[2]陈光勇, 刘丽娜, 周小鸽.α-甲酰基辅酶A消旋酶在前列腺癌诊断和鉴别诊断中的作用[J].中华病理学杂志, 2004, 33 (5) ∶419-423.

[3]Jiang Z, Fanger GR, Woda BA, et al.Expression of alpha-methyl-acyl-coA racemase (P504S) in various malignant neoplasms andnormal tissues.a study of 761 cases[J].Hum Pathol, 2003, 34 (8) ∶792-796.

[4]Guzman G, Wu SJ, Kajdacsy-Balla A, et al.alpha-methylacyl-coA racemase (AMACR/P504S) can distinguish hepatocellular car-cinoma and dysplastic hepatocytes from benign nondysplastic hepato-cytes[J].Appl Immunohistochem Mol Morphol, 2006, 14 (4) ∶411-416.

[5]Mccluggage WG, Young RH.Immunohistochemistry as a diagnosticaid in the evaluation of ovarian turmors[J].Semi Diagn Pathol, 2005, 22 (1) ∶3-32.

[6]Langner C, Rupar G, Leibl S, et al.Alpha-methylacyl-coArace-mase (AMACR/P504S) protein expression in urothelial carcinomaof the upper urinary tract correlates with turmor progression[J].Vir-chows Arch, 2006, 448 (3) ∶325-330.

[7]Oramoto H, Suqiok, Ovama T, et al.Expression of the P53 familyin lung cancer[J].Anticancer Res, 2006, 26 (3A) ∶1785-1790.

[8]Morita N, Uramoto H, Nakata S, et al.Expression of delta NP63 insquamous cell carcinoma of the esophagus[J].Anticancer Res, 2005, 25 (5) ∶3533-3539.

[9]Gickman JN, Yang A, Shahsafaci A, et al.Expression of P53 relat-ed protein P63 in the gastro-intestinal tract and in esophageal meta-plastic and neoplastic disorders[J].Hum Pathol, 2001, 32 (11) ∶1157-1165.

[10]Malaquarneaa R, Vella V, Vipneri R, et al.P53 family proteins inthyroid cancer[J].Endocr Relat Cancer, 2007, 14 (1) ∶43-60.

[11]Candi E, Dinsdale D, Rufini A, et al.TA P63 and delta NP63 incancer and epidermal development[J].Cell Cycl, 2007, 6 (3) ∶274-285.

[12]Banbieri CE, Tang LJ, Brown KA, et al.Loss of P63 leads to in-creased cell migration and up-regulation of genes involved in inva-sion and metastasis[J].Cancer Res, 2006, 66 (15) ∶7589-7597.

[13]Jiang Z, Fanger GR, Banner BF, et al.Adietary enzyme;alpha-methylacyl-coA racemase/P504S in overexpressed in colon carcino-ma[J].Cancer Detect Pre, 2003, 27 (6) ∶422-426.

[14]Malagnamera R, Mandarino A, Mazzon E, et al.The P53-ho-mologene P63 may promote thyroid cancer progression[J].EndocrRelat Cancer, 2005, 12 (4) ∶953-971.

[15]Narahashi T, Niki T, Wang T, et al.Cytoplasmic localization ofP63 is associatal with poor patient surviral in lungadenocarcinoma[J].Histopathology, 2006, 49 (4) ∶349-357.

施引文献

资源附件(0)

访问统计